Enhanced Sensitivity to IL-2 Signaling Regulates the Clinical Responsiveness of IL-12–Primed CD8+ T Cells in a Melanoma ModelDominique N. Lisiero, Robert M. Prins|The Journal of Immunology|2011Cited by 25
Enhancing adoptive T cell transfer therapies: Novel treatments through IL-12 CD8 T cell priming and adjunctive use of a histone deacetylase inhibitorDominique N. Lisiero|eScholarship (California Digital Library)|2012Cited by 0